Hydroxychloroquine decreases human MSC‐derived osteoblast differentiation and mineralization in vitro

We recently showed that patients with primary Sjögren Syndrome (pSS) have significantly higher bone mineral density (BMD) compared to healthy controls. The majority of those patients (69%) was using hydroxychloroquine (HCQ), which may have favourable effects on BMD. To study the direct effects of HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Both, Tim, van de Peppel, H. Jeroen, Zillikens, M. Carola, Koedam, Marijke, van Leeuwen, Johannes P. T. M., van Hagen, P. Martin, van Daele, Paul L. A., van der Eerden, Bram C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783866/
https://www.ncbi.nlm.nih.gov/pubmed/28975700
http://dx.doi.org/10.1111/jcmm.13373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783866/
https://www.ncbi.nlm.nih.gov/pubmed/28975700
http://dx.doi.org/10.1111/jcmm.13373

Ejemplares similares